Incidence rates with 95% CI of hospitalized infections overall and by potentially vaccine-preventable organisms of HCT vs comparison groups
. | HCT . | Non-HCT . | DOL . | |||
---|---|---|---|---|---|---|
Infection type* . | Events, n . | Incidence per 1000 PYs (95% CI) . | Events, n . | Incidence per 1000 PYs (95% CI) . | Events, n . | Incidence per 1000 PYs (95% CI) . |
H influenzae | 13 | 1.3 (0.7-2.2) | 16 | 0.5 (0.3-0.8) | 5 | 0.05 (0.02-0.1) |
Hepatitis A | 0 | — | 0 | — | 1 | 0.01 (0.001-0.06) |
Hepatitis B | 11 | 1.1 (0.6-2.0) | 10 | 0.3 (0.2-0.6) | 9 | 0.08 (0.04-0.2) |
Influenza A and B | 26 | 2.6 (1.7-3.8) | 13 | 0.4 (0.2-0.7) | 9 | 0.08 (0.04-0.2) |
N meningitidis | 2 | 0.2 (0.05-0.8) | 0 | — | 0 | — |
S pneumoniae | 30 | 3.0 (2.1-4.2) | 22 | 0.7 (0.5-1.1) | 17 | 0.16 (0.10-0.25) |
V zoster | 46 | 4.5 (3.4-6.1) | 75 | 2.4 (1.9-3.0) | 10 | 0.1 (0.05-0.2) |
Vaccine-preventable infections, all | 126 | 12.4 (10.4-14.8) | 133 | 4.3 (3.6-5.0) | 49 | 0.4 (0.3-0.6) |
Vaccine-preventable infections, limited† | 69 | 6.8 (5.4-8.6) | 51 | 1.6 (1.2-2.1) | 30 | 0.3 (0.2-0.4) |
. | HCT . | Non-HCT . | DOL . | |||
---|---|---|---|---|---|---|
Infection type* . | Events, n . | Incidence per 1000 PYs (95% CI) . | Events, n . | Incidence per 1000 PYs (95% CI) . | Events, n . | Incidence per 1000 PYs (95% CI) . |
H influenzae | 13 | 1.3 (0.7-2.2) | 16 | 0.5 (0.3-0.8) | 5 | 0.05 (0.02-0.1) |
Hepatitis A | 0 | — | 0 | — | 1 | 0.01 (0.001-0.06) |
Hepatitis B | 11 | 1.1 (0.6-2.0) | 10 | 0.3 (0.2-0.6) | 9 | 0.08 (0.04-0.2) |
Influenza A and B | 26 | 2.6 (1.7-3.8) | 13 | 0.4 (0.2-0.7) | 9 | 0.08 (0.04-0.2) |
N meningitidis | 2 | 0.2 (0.05-0.8) | 0 | — | 0 | — |
S pneumoniae | 30 | 3.0 (2.1-4.2) | 22 | 0.7 (0.5-1.1) | 17 | 0.16 (0.10-0.25) |
V zoster | 46 | 4.5 (3.4-6.1) | 75 | 2.4 (1.9-3.0) | 10 | 0.1 (0.05-0.2) |
Vaccine-preventable infections, all | 126 | 12.4 (10.4-14.8) | 133 | 4.3 (3.6-5.0) | 49 | 0.4 (0.3-0.6) |
Vaccine-preventable infections, limited† | 69 | 6.8 (5.4-8.6) | 51 | 1.6 (1.2-2.1) | 30 | 0.3 (0.2-0.4) |